Back to News
Market Impact: 0.35
Lonza Group To Buy Merck's CDMO Business
Source: Nasdaq
M&A & RestructuringHealthcare & BiotechCompany Fundamentals
Lonza agreed to acquire five CDMO sites in the U.S. from Merck KGaA. The report provides no transaction value or closing timeline.
AllMind Terminal
AI-powered research, real-time alerts, and portfolio analytics for institutional investors.
Request TrialMarket Sentiment
Overall Sentiment
mildly positive
Sentiment Score
0.20
Ticker Sentiment
LONN0.60
More News
- Binance co-CEO Richard Teng says hackers used fake job interviews, AI tool to steal $6.3 billion in crypto 108511116
- AMD stock jumps 7% on earnings as data center revenue nearly doubles
- Marvell-Lumentum Deal Puts Optical Networking at the Center of the AI Boom
- Marvell Technology could plunge on latest multibillion-dollar acquisition
- Disney Plans Thousands of Layoffs Companywide
- AMD rides data center riches to ‘largest and most profitable’ quarter in history